Cargando…
Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapy
The identification of patients who will respond to anti-tumor necrosis factor alpha (anti-TNF-α) therapy will improve the efficacy, safety, and economic impact of these agents. We investigated whether killer cell immunoglobulin-like receptor (KIR) genes are related to response to anti-TNF-α therapy...
Autores principales: | McGeough, Cathy M., Berrar, Daniel, Wright, Gary, Mathews, Clare, Gilmore, Paula, Cunningham, Rodat T., Bjourson, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364412/ https://www.ncbi.nlm.nih.gov/pubmed/21373785 http://dx.doi.org/10.1007/s00296-011-1838-6 |
Ejemplares similares
-
ATRPred: A machine learning based tool for clinical decision making of anti-TNF treatment in rheumatoid arthritis patients
por: Prasad, Bodhayan, et al.
Publicado: (2022) -
CD169+ Monocyte and Regulatory T Cell Subsets Are Associated with Disease Activity in Rheumatoid Arthritis
por: Eakin, Amanda J., et al.
Publicado: (2022) -
Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritis
por: Thomson, Ty M., et al.
Publicado: (2015) -
Dental Legislation
por: McGeough, James A.
Publicado: (1903) -
Hydroxychloroquine-Induced Myopathy Responding to Intravenous Immunoglobulin (IVIG)
por: Almoallim, Hani, et al.
Publicado: (2023)